<DOC>
	<DOCNO>NCT00002543</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : : Phase I trial study effectiveness gallium nitrate young patient malignant brain tumor , neuroblastoma , rhabdomyosarcoma , non-Hodgkin 's lymphoma , refractory solid tumor .</brief_summary>
	<brief_title>Gallium Nitrate Treating Children With Brain Tumor , Neuroblastoma , Rhabdomyosarcoma , Non-Hodgkin 's Lymphoma , Refractory Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety side effect gallium nitrate ( GAN ) use anticancer agent pediatric patient refractory solid tumor , include malignant brain tumor , neuroblastoma , rhabdomyosarcoma , non-Hodgkin 's lymphoma . II . Evaluate side effect patient . OUTLINE : Single-Agent Chemotherapy . Gallium Nitrate , GAN , NSC-15200 . PROJECTED ACCRUAL : At least 3 patient accrue dose study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Gallium nitrate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven rhabdomyosarcoma , nonHodgkin 's lymphoma , solid tumor refractory conventional therapy effective curative therapy know Rebiopsy required disease recur 2 year initial diagnosis recommend radiographic abnormality suggest tumor recurrence within 5 month complete radiotherapy chemotherapy PATIENT CHARACTERISTICS : Age : 21 diagnosis Performance status : Karnofsky 50 % 100 % Life expectancy : More 4 week Hematopoietic : ( unless extensive bone marrow involvement ) ANC great 750 Platelets great 75,000 Hepatic : Not specify Renal : Creatinine normal age OR Glomerular filtration rate least 50 mL/min per 1.73 square meter Other : Adequate nutritional status No serious uncontrolled infection No pregnant nursing woman PRIOR CONCURRENT THERAPY : At least 2 week since anticancer therapy recover Prior radiotherapy surgery symptomatic lesion allow provide site evaluable disease remain untreated Prior bone marrow stem cell transplantation allow No concurrent anticancer therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood brain tumor</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
</DOC>